Literature in Oncology: Digestive Tumours
Revheim ME, Haugvik SP, Johnsrud K, Mathisen O, Fjeld JG, Skretting A.
Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases.
Acta Radiol. 2014 Mar 28. [Epub ahead of print]
Georgakopoulos A, Pianou N, Kelekis N, Chatziioannou S.
Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases.
Clin Imaging. 2013 May-Jun;37(3):536-41. doi: 10.1016/j.clinimag.2012.09.011. Epub 2012 Oct 30.
Heijmen L, de Geus-Oei LF, de Wilt JH, Visvikis D, Hatt M, Visser EP, Bussink J, Punt CJ, Oyen WJ, van Laarhoven HW.
Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1858-67.
Jones C, Badger SA, McKie LD, Diamond T, Taylor MA, Lynch TB.
PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases.
Eur J Surg Oncol. 2012 Dec;38(12):1184-8. doi: 10.1016/j.ejso.2012.07.001. Epub 2012 Aug 9.
Muralidharan V, Kwok M, Lee ST, Lau L, Scott AM, Christophi C.
Prognostic ability of 18F-FDG PET/CT in the assessment of colorectal liver metastases.
J Nucl Med. 2012 Sep;53(9):1345-51.
Fin L, Daouk J, Bailly P, Slama J, Morvan J, El Esper I, Régimbeau JM, Chatelain D, Diouf M, Meyer ME.
Improved imaging of intrahepatic colorectal metastases with 18F-fluorodeoxyglucose respiratory-gated positron emission tomography.
Nucl Med Commun. 2012 Jun;33(6):656-62.
Frankel TL, Gian RK, Jarnagin WR.
Preoperative imaging for hepatic resection of colorectal cancer metastasis.
J Gastrointest Oncol. 2012 Mar;3(1):11-8.
McLeish AR, Lee ST, Byrne AJ, Scott AM.
Impact of ¹⁸F-FDG-PET in decision making for liver metastectomy of colorectal cancer.
ANZ J Surg. 2012 Jan-Feb;82(1-2):30-5.
Engledow AH, Skipworth JR, Pakzad F, Imber C, Ell PJ, Groves AM.
The role of 18FDG PET/CT in the management of colorectal liver metastases.
HPB (Oxford). 2012 Jan;14(1):20-5.
Briggs RH, Chowdhury FU, Lodge JP, Scarsbrook AF.
Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Clin Radiol. 2011 Dec;66(12):1167-74. doi: 10.1016/j.crad.2011.07.046. Epub 2011 Aug 24.
Han A, Xue J, Zhu D, Zheng J, Yue J, Yu J.
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Cancer Epidemiol. 2011 Oct;35(5):497-500.
Ramos E, Valls C, Martinez L, Lladó L, Torras J, Ruiz S, Gamez C, Serrano T, Fabregat J, Rafecas A.
Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Ann Surg Oncol. 2011 Sep;18(9):2654-61. doi: 10.1245/s10434-011-1670-y. Epub 2011 Mar 24.
Maas M, Rutten IJ, Nelemans PJ, Lambregts DM, Cappendijk VC, Beets GL, Beets-Tan RG.
What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.
Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1560-71.
Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM.
Value of PET/CT in the management of liver metastases, part 1.
AJR Am J Roentgenol. 2011 Aug;197(2):W256-9.
Patel S, McCall M, Ohinmaa A, Bigam D, Dryden DM.
Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review.
Ann Surg. 2011 Apr;253(4):666-71.
Strasberg SM, Dehdashti F.
Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
J Surg Oncol. 2010 Dec 15;102(8):955-9.
Kitajima K, Murakami K, Yamasaki E, Kaji Y, Shimoda M, Kubota K, Suganuma N, Sugimura K.
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Mol Imaging Biol. 2010 Aug;12(4):452-9.
Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, Fischer D.
PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
J Nucl Med. 2005 May;46(5):758-62.